(VIANEWS) – KITRON (KIT.OL), NEOEN (NEOEN.PA), NORSKE SKOG (NSKOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KITRON (KIT.OL)
1046.9% sales growth and 22.67% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, China, Malaysia, and the United States. It manufactures and sells electronics that are embedded in the customer's own products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high-level assembly lines, and environmental durability testing. Its services comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance, as well as logistics and distribution, and product deployment services. The company markets its services to connectivity, electrification, industry, medical devices, and defence/aerospace sectors. Kitron ASA was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr2.23.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 13.15. Meaning, the purchaser of the share is investing kr13.15 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.67%.
Moving Average
KITRON’s worth is way under its 50-day moving average of kr34.85 and way below its 200-day moving average of kr33.23.
Sales Growth
KITRON’s sales growth is negative 6.8% for the present quarter and 1046.9% for the next.
Volume
Today’s last reported volume for KITRON is 436003 which is 6.13% below its average volume of 464495.
More news about KITRON.
2. NEOEN (NEOEN.PA)
48.5% sales growth and 3.27% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €0.94.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 27.91. Meaning, the purchaser of the share is investing €27.91 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.27%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.7%, now sitting on 503.1M for the twelve trailing months.
Sales Growth
NEOEN’s sales growth is 63.4% for the ongoing quarter and 48.5% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 20, 2024, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 0.39%.
Yearly Top and Bottom Value
NEOEN’s stock is valued at €26.24 at 22:20 EST, way below its 52-week high of €38.94 and way above its 52-week low of €21.80.
More news about NEOEN.
3. NORSKE SKOG (NSKOG.OL)
32.1% sales growth and 8.63% return on equity
Norske Skog ASA engages in the production and sale of publication and packaging paper products in Norway, rest of Europe, North America, Australasia, Asia, and Africa. It operates in Publication paper Europe, Publication paper Australasia, and Packaging paper segments. The company offers newsprint paper products comprising standard newsprint and other papers; magazine papers, including super calendared and lightweight coated papers; and recycled containerboards. Its products are primarily used in newspapers and magazines, periodicals, catalogues, brochures, advertising materials, inserts/flyers, supplements, free-sheets, directories, direct mail, and books. Norske Skog ASA was founded in 1962 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORSKE SKOG has a trailing twelve months EPS of kr5.72.
PE Ratio
NORSKE SKOG has a trailing twelve months price to earnings ratio of 6.26. Meaning, the purchaser of the share is investing kr6.26 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.63%.
Volume
Today’s last reported volume for NORSKE SKOG is 63411 which is 65.02% below its average volume of 181327.
More news about NORSKE SKOG.
4. NORWEGIAN AIR SHUT (NAS.OL)
27.8% sales growth and 37.41% return on equity
Norwegian Air Shuttle ASA, together with its subsidiaries, provides air travel services in Norway and internationally. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. It operates a fleet of 87 aircrafts. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr1.59.
PE Ratio
NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 7.64. Meaning, the purchaser of the share is investing kr7.64 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.41%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 2.8% and a negative 92.3%, respectively.
More news about NORWEGIAN AIR SHUT.
5. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. The company was incorporated in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.48.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 20.03. Meaning, the purchaser of the share is investing kr20.03 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BOUVET’s EBITDA is 40.45.
Volume
Today’s last reported volume for BOUVET is 37703 which is 27.49% below its average volume of 52001.
Sales Growth
BOUVET’s sales growth is 12.3% for the current quarter and 9.7% for the next.
Moving Average
BOUVET’s value is above its 50-day moving average of kr63.78 and way higher than its 200-day moving average of kr62.05.
More news about BOUVET.
6. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 22:20 EST, way under its 52-week high of €106.14 and way above its 52-week low of €80.60.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 5.2% and positive 0.8% for the next.
More news about SANOFI.
7. CREDIT AGRICOLE (ACA.PA)
6.1% sales growth and 7.17% return on equity
Crédit Agricole S.A. provides retail, corporate, insurance, and investment banking products and services in France and internationally. It operates through French Retail Banking – Regional Banks; French Retail Banking – LCL; International Retail Banking; Asset Gathering; Large Customers; and Specialised Financial Services segments. The company offers banking products and services, finance, savings, wealth management, payment, and cash flow management services; consumer finance products; savings/retirement, death and disability/creditor/group, and property and casualty insurance products; investment solutions; and banking and specialized financial services. It also provides investment banking, structured finance, international trade finance, commercial banking, capital market, and syndication services; financing solutions for property and equipment investment and renewal requirements; trade receivable financing and management solutions for corporates; asset servicing solutions for investment products, as well as various asset classes, such as execution, clearing, forex, security lending and borrowing, custody, depositary bank, fund administration, middle-office outsourcing solutions, and fund distribution support and issuer services; and online banking services. The company serves retail customers, corporates, banks and financial institutions, government agencies, and local authorities. Crédit Agricole S.A. was founded in 1894 and is headquartered in Montrouge, France. Crédit Agricole S.A. operates as a subsidiary of SAS Rue La Boetie.
Earnings Per Share
As for profitability, CREDIT AGRICOLE has a trailing twelve months EPS of €1.94.
PE Ratio
CREDIT AGRICOLE has a trailing twelve months price to earnings ratio of 7.12. Meaning, the purchaser of the share is investing €7.12 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.17%.
Moving Average
CREDIT AGRICOLE’s worth is higher than its 50-day moving average of €13.80 and higher than its 200-day moving average of €13.64.
Sales Growth
CREDIT AGRICOLE’s sales growth is 3.3% for the ongoing quarter and 6.1% for the next.
Volume
Today’s last reported volume for CREDIT AGRICOLE is 5518710 which is 18.64% above its average volume of 4651440.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 29, 2024, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 7.26%.
More news about CREDIT AGRICOLE.
